FDA Approves Combination Drug to Treat Patients with Advanced Colorectal Cancer - NCI
Le fruquintinib prolonge durée de survie dans les cas de cancer colorectal métastatique réfractaire
Nanotechnologies for the treatment of colon cancer: From old drugs to new hope - ScienceDirect
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer - Clinical Trials Arena
Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer - The ASCO Post
LONSURF Dosage & Rx Info | Uses, Side Effects
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice - ScienceDirect
Servier et Taiho Oncology présentent des données sur la survie globale de trifluridine/tipiracil (LONSURF®) en association avec le bevacizumab chez des patients atteints d'un cancer colorectal métastatique réfractaire... | Business Wire
Avastin and Lonsurf for Advanced Colorectal Cancer - NCI
Current Oncology | Free Full-Text | Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer—A Single UK Centre Experience
Trifluridine/tipiracil plus bevacizumab prolongs survival in refractory colorectal cancer
Pharmaceutical Technology
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? - The Lancet Oncology
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
NCCN® Guidelines for Metastatic Colon Cancer Treatment
La FDA approuve Lonsurf plus bevacizumab pour le traitement du cancer colorectal métastatique
Lonsurf (trifluridine/tipiracil) 20mg Tablet ^ Price in Pakistan - MedicalStore.com.pk
Lonsurf Trifluridine And Tipiracil 15mg Tablets at Rs 14678/box | Lonsurf in New Delhi | ID: 2853311495673
Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer
Un anticancéreux de Servier obtient son AMM européenne | Le Quotidien du Pharmacien
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study | British Journal of Cancer
Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer - Clinical Trials Arena
LONSURF® (trifluridine and tipiracil) tablets | Previously Treated mCRC Treatment | TAS-102 Efficacy
Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer
Quebec Becomes First Province to List LONSURF® (Trifluridine/Tipiracil) for Public Reimbursement for Adult Patients with Metastatic Colorectal Cancer
Combination extends OS in metastatic colorectal cancer
